RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Events

2018 Annual General Meeting of Shareholders

June 19, 2018
2018

The Annual General Meeting of Shareholders of QIAGEN N.V. ("AGM") was held on June 19, 2018 at 10:30 a.m., CET, at Maaspoort, Oude Markt 30, 5911 HH Venlo, The Netherlands.

On May 22,2018 the total number of shares of the Company issued was 230,829,308.67 and the number of voting rights was 227,256,534. The number of voting rights does not include the treasury shares held by the Company and the fractional shares.

A webcast of the AGM was hosted on June 19, 2018 at 10:30 a.m. CET.